Revenue reached $455.3M in 2026Q3 with a combined ratio of 86.2%, but net income of $49.8M and EPS of $1.09 (down 0.9% year over year) suggest top-line growth is not yet translating fully into bottom-line gains.
Skyward Specialty Insurance Group, Inc. (SKWD) annual income statement — 7-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'13 |
|---|
| Revenue | 1.71B | 1.41B | 1.15B | 895.4M | 636.4M | 535.82M | 447.89M | 218.24M |
| Revenue Growth % | 28.08% | 23.18% | 28.17% | 40.7% | 18.77% | 19.63% | 105.23% | - |
| Medical Costs & Claims | 1.06B | 795.02M | 819.78M | 623.75M | 468.21M | 401.47M | 399.15M | 0 |
| Medical Cost Ratio % | 62.01% | 56.24% | 71.43% | 69.66% | 73.57% | 74.93% | 89.12% | 0% |
| Gross Profit | 651.73M | 622.11M | 327.89M | 271.65M | 168.2M | 134.35M | 48.73M | 218.24M |
| Gross Margin % | 38.03% | 44.01% | 28.57% | 30.34% | 26.43% | 25.07% | 10.88% | 100% |
| Gross Profit Growth % | - | 89.73% | 20.7% | 61.51% | 25.19% | 175.68% | -77.67% | - |
| Operating Expenses | 407.8M | 405.68M | 175.15M | 161.55M | 118.42M | 86.04M | 143.27M | 197.19M |
| OpEx / Revenue % | 23.8% | 28.7% | 15.26% | 18.04% | 18.61% | 16.06% | 31.99% | 90.36% |
| Depreciation & Amortization | 27M | 3.54M | 3.36M | 3.89M | 4.1M | 5.6M | 5.99M | 0 |
| Combined Ratio % | 85.81% | 84.94% | 86.69% | 87.7% | 92.18% | 90.98% | 121.11% | 90.36% |
| Operating Income | 243.92M | 216.42M | 152.74M | 110.1M | 49.78M | 48.31M | -94.53M | 21.05M |
| Operating Margin % | 14.23% | 15.31% | 13.31% | 12.3% | 7.82% | 9.02% | -21.11% | 9.64% |
| Operating Income Growth % | - | 41.7% | 38.73% | 121.16% | 3.05% | 151.1% | -549.17% | - |
| EBITDA | 270.93M | 219.96M | 156.1M | 113.99M | 53.88M | 53.91M | -88.55M | 16.74M |
| EBITDA Margin % | 15.81% | 15.56% | 13.6% | 12.73% | 8.47% | 10.06% | -19.77% | 7.67% |
| Interest Expense | 25.82M | 7.92M | 9.5M | 10.02M | 6.41M | 4.62M | 5.53M | 0 |
| Non-Operating Income | -25.82M | -7.92M | -9.5M | -10.02M | -6.41M | -4.62M | -5.53M | 4.31M |
| Pretax Income | 243.92M | 216.42M | 152.74M | 110.1M | 49.78M | 48.31M | -94.53M | 16.74M |
| Pretax Margin % | 14.23% | 15.31% | 13.31% | 12.3% | 7.82% | 9.02% | -21.11% | 7.67% |
| Income Tax | 52.13M | 46.4M | 33.91M | 24.12M | 10.39M | 9.99M | -19.89M | 5.86M |
| Effective Tax Rate % | 21.37% | 21.44% | 22.2% | 21.91% | 20.86% | 20.68% | 21.04% | 35% |
| Net Income | 191.79M | 170.03M | 118.83M | 85.98M | 39.4M | 38.32M | -74.64M | 10.88M |
| Net Margin % | 11.19% | 12.03% | 10.35% | 9.6% | 6.19% | 7.15% | -16.67% | 4.98% |
| Net Income Growth % | 35.83% | 43.09% | 38.2% | 118.26% | 2.82% | 151.33% | -786.11% | - |
| EPS (Diluted) | 4.19 | 4.07 | 2.87 | 2.24 | 1.05 | 1.18 | -2.14 | 0.29 |
| EPS Growth % | 26.25% | 41.81% | 28.13% | 113.33% | -11.02% | 155.14% | -837.93% | - |
| EPS (Basic) | - | 4.21 | 2.96 | 2.34 | 1.05 | 1.18 | -1.99 | 0.29 |
| Diluted Shares Outstanding | 45.8M | 41.87M | 41.38M | 38.32M | 37.6M | 32.47M | 34.93M | 37.6M |
Quick answers to the most common questions about buying SKWD stock.
For fiscal year 2025, Skyward Specialty Insurance Group, Inc. (SKWD) reported total revenue of $1.41B. This represents a 547.8% increase compared to $218.2M in 2013.
Skyward Specialty Insurance Group, Inc. (SKWD) is profitable, generating $170.0M in net income for the fiscal year ending 2025 with a net profit margin of 12.0%.
Skyward Specialty Insurance Group, Inc. (SKWD) reported an operating income of $216.4M, resulting in an operating profit margin of 15.3%. This margin reflects the operational efficiency of the business before interest and taxes.
Skyward Specialty Insurance Group, Inc. (SKWD) generated $622.1M in gross profit for the year, representing a gross profit margin of 44.0%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Commercial auto social inflation
Metrics are mathematically derived from official filings.
Premium Growth Moderating From Peak Levels
Based on the reported quarterly income statement, SKWD's total revenue grew 19.1% year over year in 2026Q3 to $455.3M, down from 48.7% in 2026Q2, suggesting the rapid expansion phase may be slowing as the hard market pricing tailwind matures.
The sequential deceleration from the 2026Q2 spike indicates that the earlier growth may have been partly driven by favorable pricing and timing effects rather than purely by sustained new business volume. Investors should monitor whether premium growth can persist without rate increases, since the data does not disclose policy count or retention metrics that would confirm underlying demand. A slowing top line in a hard market could signal that competitive pressure is beginning to constrain pricing in some specialty lines.
Underwriting Profit Steady Despite Rising Volatility
As reported in the quarterly figures, SKWD's combined ratio held at 86.2% in 2026Q3 against a loss ratio of 55.1%, remaining below the 100% underwriting break-even line and indicating underwriting profitability that appears durable across recent quarters.
A combined ratio in the mid-80s implies the company is earning an underwriting margin before any investment income, which is a meaningful indicator of pricing discipline. The loss ratio, however, moved from 70.4% in 2025Q2 down to 55.1% in 2026Q3, a swing large enough to warrant scrutiny of whether reserve releases or a benign loss period contributed rather than structural improvement. Sustained combined ratios near 85% would support the thesis of niche pricing power, but the volatility across quarters suggests this should be validated against prior-year development before extrapolating.
Reserve Adequacy Requires Closer Verification
Based on SKWD's reported loss figures, the loss ratio fell from 79.2% in 2024Q4 to 55.1% in 2026Q3, a decline that may reflect improving underwriting or favorable reserve development that warrants further investigation.
The reported data does not separate current-accident-year losses from prior-year development, so the magnitude of any reserve release cannot be determined from these figures alone. Given the company's exposure to long-tail casualty lines, a sharp fall in loss ratio could indicate that earlier reserves were conservative, or alternatively that newer liabilities are being recognized with optimistic initial estimates. Investors should monitor future reserve development disclosures before treating the lower loss ratio as a sustainable earnings base.
Earnings Miss Challenges Margin Narrative
Per the reported figures, SKWD's 2026Q3 EPS of $1.09 trailed the $1.26 consensus expectation by roughly 13.5%, even as revenue grew 19.1%, raising questions about whether top-line growth is translating into bottom-line results.
The gap between strong revenue growth and a per-share earnings shortfall may suggest that expense pressure, reserve strengthening, or non-recurring items offset premium gains, though the data alone cannot identify the driver. Because management provided no formal guidance, the market has limited visibility into whether the 86.2% combined ratio represents a new run-rate. This divergence warrants monitoring as a potential early signal that the earnings trajectory may be less durable than the headline margin profile implies.
Expense Scale Supports Operating Leverage
According to reported quarterly figures, SKWD's operating income reached $63.6M in both 2026Q3 and 2026Q2, flat sequentially despite revenue swings, which may indicate expense growth is keeping pace with premium volume.
A flat operating income line against fluctuating revenue suggests the company's expense base is scaling roughly in step with premiums rather than gaining operating leverage. The reported data does not break out acquisition costs or technology spend, so the efficiency of the expense ratio cannot be fully assessed. Investors should monitor whether incremental premiums begin to drop more directly to operating income as the platform matures.